|Articles|October 1, 2002

Mohs outcomes improve cost, efficiency

Los Angeles - The use of Mohs surgery to treat facial nonmelanoma skin cancer offers significant clinical and financial benefits when compared with standard surgical excisions, said Tracy L. Bialy, M.D., M.P.H.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME